Display options
Cite
Okuda T, Asano K, Numata N, et al. Feasibility of cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study. Neuropsychiatr Dis Treat. 2017;13:2185-2191doi: 10.2147/NDT.S141555.
Okuda, T., Asano, K., Numata, N., Hirano, Y., Yamamoto, T., Tanaka, M., Matsuzawa, D., Shimizu, E., Iyo, M., & Nakazato, M. (2017). Feasibility of cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study. Neuropsychiatric disease and treatment, 132185-2191. https://doi.org/10.2147/NDT.S141555
Okuda, Tomoko, et al. "Feasibility of cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study." Neuropsychiatric disease and treatment vol. 13 (2017): 2185-2191. doi: https://doi.org/10.2147/NDT.S141555
Okuda T, Asano K, Numata N, Hirano Y, Yamamoto T, Tanaka M, Matsuzawa D, Shimizu E, Iyo M, Nakazato M. Feasibility of cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study. Neuropsychiatr Dis Treat. 2017 Aug 16;13:2185-2191. doi: 10.2147/NDT.S141555. eCollection 2017. PMID: 28860776; PMCID: PMC5565247.
Copy Download .nbib Format: NLM
Share it on

Neuropsychiatr Dis Treat. 2017 Aug 16;13:2185-2191. doi: 10.2147/NDT.S141555. eCollection 2017.

Feasibility of cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study.

Neuropsychiatric disease and treatment

Tomoko Okuda, Kenichi Asano, Noriko Numata, Yoshiyuki Hirano, Tetsuya Yamamoto, Mari Tanaka, Daisuke Matsuzawa, Eiji Shimizu, Masaomi Iyo, Michiko Nakazato

Affiliations

  1. Division of Cognitive Behavioral Science, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Chiba-shi, Chiba.
  2. Department of Psychiatry, Chibaken Saiseikai Narashino Hospital, Narashino.
  3. Research Center for Child Mental Development, Chiba University.
  4. Department of Cognitive Behavioral Physiology, Graduate School of Medicine, Chiba University.
  5. Center for Forensic Mental Health, Chiba University.
  6. Department of Psychiatry, Graduate School of Medicine, Chiba University, Chiba, Japan.

PMID: 28860776 PMCID: PMC5565247 DOI: 10.2147/NDT.S141555

Abstract

BACKGROUND: Set-shifting (SS) difficulties and weak central coherence (CC) are commonly associated with autism spectrum disorders (ASD). Cognitive remediation therapy (CRT) aims to improve such cognitive processing; however, there are no reports on CRT for patients with ASD. This pilot study aimed to provide preliminary evidence to support the use of CRT for individuals with ASD and provide data to inform future studies.

PARTICIPANTS AND METHODS: Nineteen individuals with ASD were recruited and administered a series of neuropsychological and questionnaire measures to examine cognitive function and clinical outcomes such as anxiety and depression. Participants received CRT, and cognitive function and clinical variables were re-evaluated at postintervention and after 3 months.

RESULTS: The participants demonstrated significant improvement in CC and anxiety at postintervention, which was maintained at 3-month follow-up. Although SS scores had improved with a large effect size, this was not statistically significant.

CONCLUSION: CRT improved CC and anxiety scores for individuals with ASD, suggesting that CRT is an effective treatment for individuals with ASD.

Keywords: autism spectrum disorders; central coherence; cognitive flexibility; cognitive remediation therapy

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

  1. J Gen Intern Med. 2001 Sep;16(9):606-13 - PubMed
  2. Int J Eat Disord. 2013 Sep;46(6):567-75 - PubMed
  3. J Autism Dev Disord. 2016 Mar;46(3):964-77 - PubMed
  4. Mol Autism. 2015 May 13;6:6 - PubMed
  5. J Int Neuropsychol Soc. 2009 Sep;15(5):695-703 - PubMed
  6. Int J Eat Disord. 2013 Sep;46(6):576-81 - PubMed
  7. Int J Eat Disord. 2008 Mar;41(2):143-52 - PubMed
  8. PLoS One. 2012;7(6):e39351 - PubMed
  9. Eur Eat Disord Rev. 2014 Nov;22(6):454-62 - PubMed
  10. Int J Eat Disord. 2013 Jul;46(5):492-5 - PubMed
  11. J Autism Dev Disord. 2015 Oct;45(10 ):3370-6 - PubMed
  12. J Autism Dev Disord. 2015 Mar;45(3):805-15 - PubMed
  13. Eur Eat Disord Rev. 2014 Mar;22(2):116-21 - PubMed
  14. Acta Psychiatr Scand. 1983 Jun;67(6):361-70 - PubMed
  15. J Clin Exp Neuropsychol. 2012;34(10):1009-15 - PubMed
  16. Health Policy. 1990 Dec;16(3):199-208 - PubMed
  17. Psychol Med. 2008 Sep;38(9):1371-3 - PubMed
  18. J Autism Dev Disord. 2013 Dec;43(12):2866-77 - PubMed
  19. Arch Intern Med. 2006 May 22;166(10):1092-7 - PubMed
  20. Int J Eat Disord. 2014 Jan;47(1):24-31 - PubMed
  21. Yale J Biol Med. 2013 Jun 13;86(2):147-56 - PubMed
  22. No To Hattatsu. 2010 Nov;42(6):421-6 - PubMed
  23. Shinrigaku Kenkyu. 2004 Apr;75(1):78-84 - PubMed
  24. Mol Autism. 2013 Jul 31;4(1):24 - PubMed
  25. Eur Eat Disord Rev. 2016 Jan;24(1):69-74 - PubMed
  26. J Autism Dev Disord. 2011 Feb;41(2):135-47 - PubMed
  27. J Autism Dev Disord. 2006 Jan;36(1):5-25 - PubMed
  28. J Int Neuropsychol Soc. 1996 May;2(3):249-55 - PubMed
  29. Mol Autism. 2013 Nov 12;4(1):44 - PubMed
  30. Br J Psychiatry. 1999 Nov;175:444-51 - PubMed
  31. J Autism Dev Disord. 2012 Jun;42(6):1094-103 - PubMed
  32. Psychol Med. 2016 Jul;46(9):1809-27 - PubMed

Publication Types